Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Imagine getting your own personalized medical treatment for an illness – say, diabetes or cancer – created using all the biological, medical, behavioral and environmental information known about you. iLoF, a Porto- and Oxford-based precision medicine startup, is working to make that possible, from needing just a single drop of blood from the patient.The goal: better predictions and preventative measures in early diagnostics, as well as accelerating and optimizing drug and treatment development – through inexpensive and non-invasive patient screening and stratification."iLoF was born...
Edited by Bernice Tang